Tower Research Capital LLC (Trc) Cue Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,542 shares of CUE stock, worth $14,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,542

Previous 7,217 46.07%

Holding current value

$14,126

Previous $5,000 100.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.71 - $1.88 $2,360 - $6,251	3,325 Added 46.07%	10,542 $10,000
Q3 2024 Nov 14, 2024	SELL	$0.45 - $1.08 $1,873 - $4,497	-4,164 Reduced 36.59%	7,217 $5,000
Q2 2024 Aug 13, 2024	BUY	$1.24 - $2.18 $10,060 - $17,686	8,113 Added 248.26%	11,381 $14,000
Q1 2024 May 15, 2024	SELL	$1.77 - $3.09 $2,879 - $5,027	-1,627 Reduced 33.24%	3,268 $6,000
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.1 $1,088 - $1,962	-633 Reduced 11.45%	4,895 $12,000
Q3 2023 Nov 14, 2023	BUY	$2.23 - $4.69 $6,054 - $12,733	2,715 Added 96.52%	5,528 $12,000
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $8,748 - $13,811	2,813 New	2,813 $10,000
Q3 2022 Nov 10, 2022	SELL	$2.23 - $3.37 $5,833 - $8,815	-2,616 Reduced 47.37%	2,906 $6,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $5.92 $5,600 - $13,314	2,249 Added 68.71%	5,522 $13,000
Q1 2022 May 12, 2022	BUY	$4.41 - $12.28 $3,969 - $11,052	900 Added 37.93%	3,273 $16,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $17.85 $4,496 - $7,389	-414 Reduced 14.85%	2,373 $27,000
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $23,580 - $35,863	-2,344 Reduced 45.68%	2,787 $41,000
Q2 2021 Aug 16, 2021	BUY	$10.9 - $14.53 $41,910 - $55,867	3,845 Added 298.99%	5,131 $60,000
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $23,105 - $33,193	-2,063 Reduced 61.6%	1,286 $16,000
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $24,108 - $35,555	2,168 Added 183.57%	3,349 $42,000
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $97,358 - $152,280	-6,469 Reduced 84.56%	1,181 $18,000
Q2 2020 Aug 13, 2020	BUY	$12.7 - $30.73 $97,155 - $235,084	7,650 New	7,650 $188,000
Q4 2019 Feb 07, 2020	SELL	$7.06 - $17.47 $3,537 - $8,752	-501 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$6.78 - $9.28 $3,396 - $4,649	501 New	501 $4,000
Q2 2019 Aug 13, 2019	SELL	$7.18 - $9.65 $14,826 - $19,927	-2,065 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$4.7 - $9.29 $92,007 - $181,861	-19,576 Reduced 90.46%	2,065 $16,000
Q4 2018 Feb 14, 2019	BUY	$4.35 - $8.73 $76,394 - $153,316	17,562 Added 430.55%	21,641 $102,000
Q3 2018 Nov 13, 2018	BUY	$7.91 - $11.89 $29,654 - $44,575	3,749 Added 1136.06%	4,079 $37,000
Q2 2018 Aug 15, 2018	SELL	$10.93 - $14.48 $907 - $1,201	-83 Reduced 20.1%	330 $4,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $4,803 - $7,124	413 New	413 $6,000

Others Institutions Holding CUE

# of Institutions

Shares Held

11.9M

Call Options Held

22K

Put Options Held

1.2K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $47.4M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Cue Biopharma, Inc. Transaction History